COMMUNIQUÉS West-GlobeNewswire

Imidex and Spesana Form Strategic Partnership to Impact Early Lung Cancer Detection and Patient Outcomes
11/07/2024
DENVER, July 11, 2024 (GLOBE NEWSWIRE) -- Spesana, a leader in personalized medicine technology for clinicians, diagnostic labs and pharmaceutical companies including the oncology specialty, and Imidex, developer of [...]
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Launch of CEO Corner Platform
11/07/2024
CEO Corner segments to include additional discussion related to press releases, events, corporate updates and pipeline progress Access the Autonomix CEO Corner Here! THE WOODLANDS, TX, July 11, 2024 (GLOBE NEWSWIRE) -- [...]
CervoMed to Host Virtual KOL Event on Neflamapimod for Dementia with Lewy Bodies on July 23, 2024
11/07/2024
Phase 2b RewinD-LB trial of neflamapimod for the treatment of dementia with Lewy bodies is fully enrolled with topline data expected in December 2024 BOSTON, July 11, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO [...]
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
11/07/2024
NeuroStar, the first and only TMS treatment cleared for adolescents, now covered by Medi-Cal MALVERN, Pa., July 11, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on [...]
Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
11/07/2024
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the [...]
Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.
11/07/2024
First Licensing Agreement for coactiv+™ Scalp Care Line WINNIPEG, Manitoba, July 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed a [...]
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
10/07/2024
CHATHAM, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced the closing of its public [...]
MEDIROM Healthcare Technologies Announces Acquisition of Japan Gene Medicine Corporation
10/07/2024
NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our”, “us” or “the Company”) hereby announces that the Company plans to acquire a majority of Japan Gene Medicine Corporation (the [...]
Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments Beginning January 1, 2025
10/07/2024
-- Proposed Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment System Rule extends separate payment from ambulatory surgical centers to include the hospital outpatient environment – -- Rule [...]
Desert Hope Treatment Center Promotes Kristin Berg to Executive Director, Solidifying its Position as a Market Leader
10/07/2024
LAS VEGAS, July 10, 2024 (GLOBE NEWSWIRE) -- Desert Hope Treatment Center, a leading addiction treatment provider in Las Vegas, is proud to announce the promotion of Kristin Berg to the position of Executive Director. [...]
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
10/07/2024
PRESS RELEASE REGULATED INFORMATION 10 July 2024, 06:00 p.m. CEST SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 10 July 2024 – Sequana Medical NV (Euronext Brussels: SEQUA [...]
GrayHawk Health Leverages Innovaccer’s Technology to Transform In-Home Healthcare for At Risk Populations
10/07/2024
PA-based GrayHawk Health will use Innovaccer’s Population Health Analytics and Data Platform to accelerate development of its healthcare experience platform (HXP) , validate quality and to improve in-home care delivery [...]
Elite MedSpa, Ivy En Rose, Unveils Groundbreaking Longevity Program and Announces Upcoming Launch of Membership Rewards
10/07/2024
SAN FRANCISCO, July 10, 2024 (GLOBE NEWSWIRE) -- Ivy En Rose , an elite medspa in San Francisco, is thrilled to announce the launch of their innovative Longevity Program, designed to help clients achieve and maintain [...]
FSH-free versus FSH-primed infertility treatment of women with polycystic ovary syndrome using biphasic in vitro maturation: a randomized clinical trial
10/07/2024
AMSTERDAM, July 10, 2024 (GLOBE NEWSWIRE) -- This randomized, controlled trial was conducted at a tertiary IVF center, Ho Chi Minh City, Vietnam. Between January 2023 and June 2023, 120 women were randomized. Eligible [...]
Shineco Announces New Distribution Agreements for over $30 Million in Sales for its New Health Food Beverage
10/07/2024
The Company believes that its Advanced Proprietary Production Technology Provides it with a Competitive Advantage in the Sector BEIJING, July 10, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; [...]
SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
10/07/2024
DENVER, July 10, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical), today announced it has entered into a definitive agreement for the issuance and sale of an aggregate of 947, [...]
Two USOSM Partner Practices Receive AAAHC Accreditation
10/07/2024
Recognition Enables Oral and Maxillofacial Surgery Centers of Excellence Distinction IRVING, Texas, July 10, 2024 (GLOBE NEWSWIRE) -- The Accreditation Association for Ambulatory Health Care ( AAAHC ) has accredited two [...]
BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents
10/07/2024
Updated criteria post-FDA clearance for NeuroStar TMS benefit youth mental health MALVERN, Pa., July 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, [...]
Skyhawk Therapeutics Announces Positive Topline Results from Parts A and B of its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease, Reaching 72% Huntingtin mRNA Reduction
10/07/2024
Skyhawk’s SKY-0515 demonstrated dose-dependent huntingtin (HTT) mRNA reduction in healthy volunteers, with 72% reduction at the highest dose tested in the multiple ascending dose study SKY-0515 was generally well [...]

Pages